SHR-1921

Atridia Pty Ltd. · Phase 2 active Small molecule

At a glance

Generic name	SHR-1921
Sponsor	Atridia Pty Ltd.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors (PHASE1)
A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SHR-1921 CI brief — competitive landscape report
SHR-1921 updates RSS · CI watch RSS
Atridia Pty Ltd. portfolio CI